Daniel K. Reynolds - Concepedia

Author

Daniel K. Reynolds

Institute for Clinical Pharmacodynamics (United States)

Also Known As

D. K. Reynolds, Daniel K. Reynolds

Publications

464

Citations

H-Index

Concepts

All Affiliations

Institute for Clinical Pharmacodynamics (United States)Astellas Pharma (United States)University at Buffalo, State University of New York University of Wisconsin–Madison

About

Daniel K. Reynolds is an author at Institute for Clinical Pharmacodynamics (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	350
2	Pharmacology	5	5	350
3	Antimicrobial Pharmacodynamics	4	4	213
4	Antibiotics	2	2	174
5	Health Sciences	1	1	29

Daniel K. Reynolds

Publications

432

Citations

H-Index

Page 1

	Year	Citations
Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous Meningitis Guy Thwaites, Sujata M. Bhavnani, Tran Thi Hong Chau, Antimicrobial Agents and Chemotherapy Intermediate ExposuresPulmonary TuberculosisAntibioticsMedicineTuberculosis Prevention	2011	137
Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia David R. Andes, Paul G. Ambrose, Jeffrey Hammel, Antimicrobial Agents and Chemotherapy Mycological ResponseAntifungal AgentPharmacokinetic-pharmacodynamic AnalysesCandida Species InhibitionAntifungal Agents	2011	118
Trends in Prevalence of Obesity and Overweight among Children Enrolled in the New York State WIC Program, 2002–2007 Jackson P. Sekhobo, Lynn S. Edmunds, Daniel K. Reynolds, Public Health Reports	2010	42
Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community‐acquired bacterial pneumonia Scott A. Van Wart, Alan Forrest, Tatiana Khariton, The Journal of Clinical Pharmacology Healthy SubjectsKlebsiella PneumoniaePharmacotherapyAntimicrobial ChemotherapyPopulation Pharmacokinetics	2013	37
Clinical Pharmacodynamic Index Identification for Micafungin in Esophageal Candidiasis: Dosing Strategy Optimization David R. Andes, Daniel K. Reynolds, Scott A. Van Wart, Antimicrobial Agents and Chemotherapy Strategy OptimizationPharmacotherapyDaily AdministrationAntimicrobial ChemotherapyDrug Resistance	2013	29
Pharmacokinetic-Pharmacodynamic Determinants of Oseltamivir Efficacy Using Data from Phase 2 Inoculation Studies Craig R. Rayner, Catharine C. Bulik, Mohamed Kamal, Antimicrobial Agents and Chemotherapy Pharmacokinetic ModelingPharmacodynamicsInoculation StudiesPharmacologyOseltamivir Efficacy	2013	29
Pharmacokinetic-Pharmacodynamic Analysis for Efficacy of Ceftaroline Fosamil in Patients with Acute Bacterial Skin and Skin Structure Infections Sujata M. Bhavnani, Jeffrey Hammel, Scott A. Van Wart, Antimicrobial Agents and Chemotherapy	2014	27
Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia Sujata M. Bhavnani, Jeffrey Hammel, Scott A. Van Wart, Antimicrobial Agents and Chemotherapy	2013	13

Page 1